SHA:603707 Market Cap

SHA:603707 has a market cap or net worth of 16.06 billion as of March 18, 2026. Its market cap has decreased by -28.54% in one year.

Market Cap

16.06B

Enterprise Value

15.78B

Revenue

3.76B

Ranking

n/a

PE Ratio

24.74

Stock Price

9.89

Market Cap Chart

Since July 19, 2017, SHA:603707's market cap has increased from 4.40B to 16.06B, an increase of 265.32%. That is a compound annual growth rate of 16.12%.

Market Cap History

Date	Market Cap	% Change
Mar 18, 2026	16.06B	10.08%
Dec 31, 2025	14.59B	-31.95%
Dec 31, 2024	21.44B	-11.29%
Dec 29, 2023	24.17B	-16.87%
Dec 30, 2022	29.08B	-44.15%
Dec 31, 2021	52.06B	59.17%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Jul 19, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Tonghua Dongbao Pharmaceutical	17.72B
Hybio Pharmaceutical	16.13B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	16.03B
Guobang Pharma	16.00B
Shenzhen Kangtai Biological Products	15.88B
Guangdong Zhongsheng Pharmaceutical	15.36B
Shenzhen Hepalink Pharmaceutical Group	15.20B
Zhejiang Medicine	15.12B

Market Cap Rankings